Y-Intercept (HK)’s Abeona Therapeutics ABEO Stock Holding History

Y-Intercept (HK)’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$447K	Buy	+72,373	New	+$397K	0.01%	1343
2025 Q3	–	Sell	-102,336	Closed	-$581K	–	1513
2025 Q2	$581K	Buy	+102,336	New	+$583K	0.01%	1152
2024 Q2	–	Sell	-14,023	Closed	-$102K	–	1326
2024 Q1	$102K	Buy	14,023 +3,609	+35%	+$22.9K	0.01%	1277
2023 Q4	$52.2K	Buy	+10,414	New	+$45.8K	﹤0.01%	1159
2021 Q3	–	Sell	-609	Closed	-$24K	–	617
2021 Q2	$24K	Buy	+609	New	+$24.8K	0.01%	578

Other funds holding ABEO

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

APW

Allied Private Wealth Boca Raton, Florida $156M AUM

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

BIAS

Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

Y-Intercept (HK)'s ABEO Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Abeona Therapeutics (ABEO) in Q2 2026: 72,373 shares worth $447K. The stake represents 0.01% of the portfolio and ranks #1343 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in ABEO as recently as Q2 2025.

Y-Intercept (HK) first reported a position in ABEO in Q2 2021 and has held it in 5 quarters since. The position peaked at $581K in Q2 2025. 6 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

Y-Intercept (HK) held 72,373 shares of Abeona Therapeutics worth $447K as of Q2 2026.
Abeona Therapeutics was a new Y-Intercept (HK) position in Q2 2026.
Abeona Therapeutics made up 0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1343 holding.
Y-Intercept (HK) first reported a position in Abeona Therapeutics in Q2 2021 and has held it in 5 quarters since.
Y-Intercept (HK)'s Abeona Therapeutics position peaked at $581K in Q2 2025.
6 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.